Clinical Trial Update: Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating maintenance chemotherapy in high-metastatic risk nasopharyngeal carcinoma (N3 stage).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Fudan University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: UNKNOWN